This study aimed to elucidate the effects of messenger RNA (mRNA) and inactivated coronavirus disease 2019 (COVID-19) vaccines on ovarian histology and reserve in rats.
Methods
Thirty female Wistar albino rats, aged 16-24 weeks, were randomly divided into three groups (n = 10): control, mRNA vaccine, and inactivated vaccine groups. Each vaccine group received two doses (on day 0 and day 28) at human-equivalent doses. Four weeks post-second vaccination, ovarian tissues were harvested for analysis.
Results
Immunohistochemical analysis was performed to evaluate the expression of transforming growth factor beta-1 (TGF-β1), vascular endothelial growth factor (VEGF), caspase-3, and anti-Müllerian hormone (AMH) in ovarian follicles. Both vaccines induced significant increases in TGF-β1, VEGF, and caspase-3 expression, with more pronounced effects in the mRNA vaccine group. Conversely, AMH expression in the granulosa cells of primary, secondary, and antral follicles showed marked reductions (p < 0.001). The counts of primordial, primary, and secondary follicles decreased significantly in the inactivated vaccine group relative to controls and further in the mRNA vaccine group compared to the inactivated group (p < 0.001). Additionally, the mRNA vaccine group exhibited a decrease in antral and preovulatory follicles and an increase in atretic follicles compared to the other groups (p < 0.05). The serum AMH level was diminished with the mRNA vaccination in comparison with the control and inactivated groups.
Conclusions
Our findings suggest that both mRNA and inactivated COVID-19 vaccines may detrimentally impact ovarian reserve in rats, primarily through accelerated follicular loss and alterations in apoptotic pathways during folliculogenesis. Given these observations in a rat model, further investigations into the vaccines' effects on human ovarian reserve are needed.
COVID vaccine ovarian reserve, mRNA vaccine fertility effects, anti-müllerian hormone vaccine, ovarian function COVID vaccination, follicle loss COVID vaccine, AMH levels after vaccination, coronavirus vaccine ovaries, reproductive health COVID vaccine, ovarian reserve markers vaccine, follicular atresia vaccination, vaccine effects on fertility
Cite this article
KARAMAN, E., Yavuz, A., Karakaş, E., Balcıoğlu, E., Karaca, B., Doganay, H. N., Saçıntı, K. G., & Yıldız, O. (2025). Impact of mRNA and Inactivated COVID-19 Vaccines on Ovarian Reserve. *Vaccines*, *13*(4), 345. https://doi.org/10.3390/vaccines13040345
KARAMAN E, Yavuz A, Karakaş E, Balcıoğlu E, Karaca B, Doganay HN, et al. Impact of mRNA and Inactivated COVID-19 Vaccines on Ovarian Reserve. Vaccines (Basel). 2025;13(4):345. doi:10.3390/vaccines13040345
KARAMAN, Enes, et al. "Impact of mRNA and Inactivated COVID-19 Vaccines on Ovarian Reserve." *Vaccines*, vol. 13, no. 4, 2025, pp. 345.
Miao C et al., 2023
Open Access
Frontiers in Endocrinology
Background: Primary ovarian insufficiency (POI) is a common gynecological disease with serious ramifications including low pregnancy rate and low estrogen symptoms. Traditional Chinese medicine is reg...
Self-Worth is an over-arching evaluation of a person's sense of individual value. Self-worth, however, is an underappreciated concept. It has rarely been reported related to physiological data; we fou...
Panay N et al., 2024
Open Access
Human reproduction open
Study questionHow should premature/primary ovarian insufficiency (POI) be diagnosed and managed based on the best available evidence from published literature?Summary answerThe current guideline provi...
Panay N et al., 2024
Open Access
Climacteric : the Journal of the International Menopause Society
STUDY Question: How should premature/primary ovarian insufficiency (POI) be diagnosed and managed, based on the best available evidence from published literature? SUMMARY ANSWER: The current guideline...